Community 365 Roundtable: Ensuring equitable access to precision cancer medicine in Europe
The European Cancer Organisation is hosting a high-level Community 365 Roundtable on personalised treatment: tailoring prevention, diagnosis, and strategies to the individual characteristics of each patient.
Rather than adopting a one-size-fits-all model, we need to optimise health outcomes by considering a person’s unique genetic makeup, environment and lifestyle. But how do we ensure this level of care reaches many more Europeans?
The upcoming roundtable will bring together leading experts, policymakers, industry partners, and patient advocates to assess the current status of personalised oncology care and identify policy recommendations to expand access across all regions and patient groups.
Participants will explore the full ecosystem required to make precision cancer medicine a standard part of care. The roundtable will also inform current efforts to create ‘Essential Requirements for Quality Cancer Care in Personalised Medicine’, helping shape a future where every patient has equitable access to innovative cancer solutions.
Please join us as we explore the latest European initiatives, cross-border collaborations, and strategies for overcoming implementation barriers - moving from isolated solutions to systemic progress.
The Roundtable will be chaired by:
- Rui Medeiros, Deputy Director at the Research Centre, Instituto Português de Oncologia (IPO Porto) & Board Member of the European Cancer Organisation.
- Bettina Ryll, founder of the Melanoma Patient Network Europe (MPNE) & member of the first EU Cancer Mission Board & works on national and European PCM implementation at the Stockholm School of Economics Institute for Research.
More information on the programme and the speakers will be shared soon.
Speakers
-
Rui Medeiros Deputy Director at the Research Centre, Instituto Português de Oncologia (IPO Porto) & Board Member of the European Cancer Organisation
-
Bettina Ryll Founder of Melanoma Patient Network Europe (MPNE) & member of the first EU Cancer Mission Board
Speakers
-
Rui Medeiros Deputy Director at the Research Centre, Instituto Português de Oncologia (IPO Porto) & Board Member of the European Cancer Organisation
-
Bettina Ryll Founder of Melanoma Patient Network Europe (MPNE) & member of the first EU Cancer Mission Board
-
Rui Medeiros Deputy Director at the Research Centre, Instituto Português de Oncologia (IPO Porto) & Board Member of the European Cancer Organisation
-
Bettina Ryll Founder of Melanoma Patient Network Europe (MPNE) & member of the first EU Cancer Mission Board
Speakers
-
Rui Medeiros Deputy Director at the Research Centre, Instituto Português de Oncologia (IPO Porto) & Board Member of the European Cancer Organisation
-
Bettina Ryll Founder of Melanoma Patient Network Europe (MPNE) & member of the first EU Cancer Mission Board
| 15:00 - 15:10 | Welcome and introductions | |
| 15:10 - 15:55 | The precision cancer medicine eco-system | |
| 15:55 - 16:40 | Building on European investment in precision cancer medicine. Quo Vadis? | |
| 16:40 - 17:25 | Cost-effectiveness considerations. Smarter solutions? | |
| 17:25 - 17:30 | Event conclusions and next steps |
Speakers
-
Rui Medeiros Deputy Director at the Research Centre, Instituto Português de Oncologia (IPO Porto) & Board Member of the European Cancer Organisation
-
Bettina Ryll Founder of Melanoma Patient Network Europe (MPNE) & member of the first EU Cancer Mission Board
Speakers
-
Rui Medeiros Deputy Director at the Research Centre, Instituto Português de Oncologia (IPO Porto) & Board Member of the European Cancer Organisation
-
Bettina Ryll Founder of Melanoma Patient Network Europe (MPNE) & member of the first EU Cancer Mission Board
